Gaudium IVF IPO: Subscription Status, GMP, and Key Details
The initial public offering (IPO) of Gaudium IVF & Women Health Ltd., a Delhi-based In Vitro Fertilisation (IVF) treatment provider, opened for bidding on February 20, 2026, and is scheduled to close on February 24, 2026. The IPO aims to raise ₹165 crore from the primary market.
Gaudium IVF IPO GMP
As of February 23, 2026, the grey market premium (GMP) for the Gaudium IVF IPO stands at ₹8.50 per share. Livemint reports this indicates a potential listing price of around ₹87.50, a premium of approximately 11% over the IPO price.
Note: GMP does not represent official data and is based on market speculation.
Gaudium IVF IPO: Key Details
- IPO Size: ₹165 crore
- Fresh Issue: ₹90 crore
- Offer for Sale (OFS): ₹75 crore
- Price Band: ₹75 to ₹79 per share
- Minimum Lot Size: 189 shares
- Listing Date: Tentatively fixed as February 27, 2026
- Listing Exchanges: NSE and BSE
Gaudium IVF IPO Subscription Status
By February 23, 2026, the Gaudium IVF IPO was subscribed 2.64 times. Livemint details the following subscription levels:
- Retail Portion: Subscribed 3.66 times
- NII (Non-Institutional Investors) Segment: Subscribed 3.77 times
On the first day of bidding, February 20, 2026, the IPO was subscribed 0.88 times. Kotak Securities reported that the retail individual investors (RII) led the charge, booking their quota 1.37 times. The NII category was subscribed 0.91 times, while the Qualified Institutional Buyers’ (QIBs) category did not receive any applications on the first day.
Use of IPO Funds
Gaudium IVF and Women Health Ltd. Intends to utilize the IPO funds for the establishment of new IVF centres, repayment of debts, and general corporate purposes. Kotak Securities
About Gaudium IVF and Women Health
Incorporated in 2015, Gaudium IVF and Women Health Ltd. Provides fertility services through its centres across multiple cities in India. The company currently operates thirty locations, including two centres in Delhi and one each in Bengaluru, Mumbai, Ludhiana, Patna, and Srinagar.
Disclaimer: Investments in initial public offerings are subject to market risks. Please consult with financial advisors and read the red herring prospectus thoroughly before placing bids.